Abstract (EN):
Aim: To evaluate the effects of antioxidant treatment of streptozotocin (STZ)-diabetic rats with alpha-lipoic acid (alpha-LA) in neuronal and microglial activation at the spinal cord, an important relay station of nociceptive transmission. Because of the role of the potassium chloride co-transporter 2 (KCC2) in neuronal activation at the spinal cord and the influence of microglia in KCC2 expression, we also evaluated the effects of alpha-LA in KCC2 expression at the spinal cord. Methods: Four weeks after STZ injection, the rats received daily intraperitoneal injections of alpha-LA (100 mg/kg), during 2 weeks. Mechanical nociception was evaluated before and after alpha-LA treatment. Spinal cords were immunoreacted against 8-OH-dG (marker of oxidative stress damage), Fos (marker of neuronal activation) and CD11b (marker of microglia). KCC2 expression was evaluated by immunohistochemistry and western blotting. Results: Treatment with alpha-LA decreased the 8-OH-dG and Fos expressions to controls' levels, but did not affect CD11b. Treatment with alpha-LA alleviated mechanical hyperalgesia and partially corrected KCC2 expression. Conclusions: This study shows that neuronal hyperactivity at the spinal cord of STZ-diabetic rats can be corrected by alpha-LA, which may account for alleviation of mechanical hyperalgesia. These effects are probably partially mediated by KCC2, but are independent from microglia.
Language:
English
Type (Professor's evaluation):
Scientific
No. of pages:
6